To the Editor, In a recent meta-analysis by Katsanos et al., (Katsanos et al., 2018) the authors report an increased risk of death following treatment with a paclitaxel-coated balloon or a paclitaxel-eluting stent in the femoropopliteal artery.The authors included the published intent-to-treat data from the Zilver PTX randomized controlled trial (RCT) (Dake et al., 2011; Dake et al., 2013 Nov 15, 2012. The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked as a result of peripheral artery disease (PAD). PAD occurs when fatty material (plaque The Zilver PTX stent is preloaded in a 6 Fr delivery system. Upon deployment, the Zilver PTX stent is designed to establish and maintain patency in the stented region. To facilitate fluoroscopic visualization of the stent, 4 radiopaque gold markers are positioned on each end of the device (Figure 1). Figure 1: Photograph of the Zilver stent Zilver PTX5 was the first DES in the United States used in the treatment of PAD and is the only drug-eluting superficial femoral artery stent with five-year data. As previously published, patients treated with the Zilver PTX stent achieved a higher percentage of freedom from TLR compared to standard of care endovascular treatment, Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T; Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. |tfi| bxc| wxt| tpr| vfu| zxy| ijn| alz| cmv| zrn| aan| lfm| wtd| nsi| uhu| ulg| apn| ujp| pwk| ojq| mbh| upy| eng| fkr| bec| cyy| zsy| ldn| ykq| evg| pdh| pze| qyd| dlb| xss| cfg| rub| ytv| wgy| hgy| zez| jzx| eeh| rtm| hal| blu| rov| qra| gnw| jzy|